EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

Clinical Validation of Digital PCR for Precise m.3243A>G Heteroplasmy Quantification in Early‐Onset Diabetes

Xiaomu Kong iD, Lei Bei, Peng Gao iD, Lixia Lu iD, Haoyan Zhu iD, Yongwei Jiang iD, Meimei Zhao iD, Yi Liu iD, Guozhen Wang iD, Mo Li, Ziyi Feng iD, Guoxiong Deng iD und 2 weitere

Journal of Diabetes Research · 2026-01 · 2026 (1)

DOI: 10.1155/jdr/9298888 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Journal of Diabetes Research, online erschienen am 26.03.2026. Verfasst von Xiaomu Kong und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, China-Japan Friendship Hospital, No. 2 Yinghua East Street, Chaoyang District, Beijing, 100029, China, zryhyy.com.…. Hauptthemen laut MEDLINE: Polymerase Chain Reaction, Diabetes Mellitus, Type 2, DNA, Mitochondrial, Heteroplasmy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Elite Medical Professionals Project of China-Japan Friendship Hospital, National High Level Hospital Clinical Research Funding.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitochondrial DNA m.3243A>G variant causes maternally inherited diabetes with deafness. We developed a droplet digital PCR (dPCR) assay to quantify m.3243A>G heteroplasmy and investigated its prevalence in Chinese Han early‐onset diabetes patients.

Methods

The dPCR method was validated using plasmid mixtures (10 4 copies) for sensitivity, specificity, dynamic range (10–10 5 copies/μL), accuracy, and precision. We screened 1506 unselected early‐onset diabetes patients, analyzing blood and urinary sediment DNA. This population comprised 1474 diagnosed type 2 diabetes patients (97.88%), 31 diagnosed type 1 diabetes patients (2.06%), and one patient with mitochondrial diabetes (0.07%). The dPCR results were compared with Sanger sequencing and next generation sequencing (NGS) to evaluate the accuracy of heteroplasmy rate quantification.

Results

The dynamic range spans from 10 to 10 5 copies/μL. The assay detected heteroplasmy as low as 0.05% with 100% specificity. The method can reliably quantify the heteroplasmy rate at 0% to 100% for an input copy number of 10 4 . Using the dPCR method, we identified 0.80% ( n = 12) had >5% m.3243A>G heteroplasmy in peripheral blood and/or urinary sediment, and 0.40% ( n = 6) had 1%–5% among the early‐onset diabetes patients. The dPCR approach was more sensitive than Sanger sequencing. When compared with NGS results, the dPCR method accurately genotyped m.3243A>G and quantified its heteroplasmy rate in clinical samples. Furthermore, it demonstrated that urine is a reliable noninvasive sample source for determining the m.3243A>G heteroplasmy rate.

Conclusion

The developed method can provide an accurate, reliable, rapid, simple, and low‐cost evaluation of the heteroplasmy rate of m.3243A>G for both peripheral blood and urinary sediment. Thus, it is highly promising as a genetic screening method for early‐onset diabetes related to m.3243A>G.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymerase Chain ReactionDiabetes Mellitus, Type 2DNA, MitochondrialHeteroplasmyDiabetes Mellitus, Type 1HumansFemaleMaleAge of OnsetAdultReproducibility of ResultsSensitivity and SpecificityAsian PeopleHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

digital PCRearly-onset diabetesheteroplasmymaternally inherited diabetes and deafnessmitochondrial DNAmitochondrial diabetes mellitus

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Department of Clinical Laboratory, China-Japan Friendship Hospital, No. 2 Yinghua East Street, Chaoyang District, Beijing, 100029, China, zryhyy.com.cn.
  • Research and Development Department, TargetingOne Corporation, Beijing, China.
  • China-Japan Friendship Institute of Clinical Medicine Research, Beijing, China.

ORCID-Profile: Xiaomu Kong, Peng Gao, Lixia Lu, Haoyan Zhu, Yongwei Jiang, Meimei Zhao, Yi Liu, Guozhen Wang, Ziyi Feng, Guoxiong Deng, Yongtong Cao, Liang Ma

Förderung

  • Elite Medical Professionals Project of China-Japan Friendship Hospital
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Kong, X., Bei, L., Gao, P., Lu, L., Zhu, H., Jiang, Y., Zhao, M., Liu, Y., Wang, G., Li, M., Feng, Z., Deng, G., Cao, Y., & Ma, L. (2026). Clinical Validation of Digital PCR for Precise m.3243A>G Heteroplasmy Quantification in Early‐Onset Diabetes. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/9298888

Vancouver

Kong X, Bei L, Gao P, Lu L, Zhu H, Jiang Y, et al. Clinical Validation of Digital PCR for Precise m.3243A>G Heteroplasmy Quantification in Early‐Onset Diabetes. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/9298888

BibTeX
@article{Kong2026,
  author = {Kong, Xiaomu and Bei, Lei and Gao, Peng and Lu, Lixia and Zhu, Haoyan and Jiang, Yongwei and Zhao, Meimei and Liu, Yi and Wang, Guozhen and Li, Mo and Feng, Ziyi and Deng, Guoxiong and Cao, Yongtong and Ma, Liang},
  title = {Clinical Validation of Digital PCR for Precise m.3243A>G Heteroplasmy Quantification in Early‐Onset Diabetes},
  journal = {Journal of Diabetes Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jdr/9298888}
}
Kostenlos starten →